Seliniotaki A, Tziola T, Lithoxopoulou M, Tzamalis A, Ziakas N, Mataftsi A
Graefes Arch Clin Exp Ophthalmol. 2025; .
PMID: 40011238
DOI: 10.1007/s00417-025-06773-1.
Seliniotaki A, Lithoxopoulou M, Virgiliou C, Gika H, Dokoumetzidis A, Bougioukas K
JAMA Ophthalmol. 2024; 143(2):110-116.
PMID: 39724200
PMC: 11843355.
DOI: 10.1001/jamaophthalmol.2024.5462.
Sadeghi A, Subrizi A, Del Amo E, Urtti A
Invest Ophthalmol Vis Sci. 2024; 65(11):28.
PMID: 39287588
PMC: 11412384.
DOI: 10.1167/iovs.65.11.28.
Mochizuki T, Hata T, Mori N, Yamazaki T, Noto T, Mano H
Jpn J Ophthalmol. 2024; 68(5):594-602.
PMID: 38795193
PMC: 11420250.
DOI: 10.1007/s10384-024-01070-6.
Brugnera M, Vicario-de-la-Torre M, Gonzalez-Cela Casamayor M, Lopez-Cano J, Bravo-Osuna I, Huete-Toral F
Drug Deliv Transl Res. 2024; 14(10):2804-2822.
PMID: 38602615
PMC: 11385046.
DOI: 10.1007/s13346-024-01584-z.
Animal Models in Eye Research: Focus on Corneal Pathologies.
Loiseau A, Raiche-Marcoux G, Maranda C, Bertrand N, Boisselier E
Int J Mol Sci. 2023; 24(23).
PMID: 38068983
PMC: 10706114.
DOI: 10.3390/ijms242316661.
Applications of Nanotechnology-mediated Herbal Nanosystems for Ophthalmic Drug.
Shree D, Patra C, Sahoo B
Pharm Nanotechnol. 2023; 12(3):229-250.
PMID: 37587812
DOI: 10.2174/2211738511666230816090046.
A Physiology-Based Mathematical Model to Understand Drug Delivery from Contact Lenses to the Back of the Eye.
Toffoletto N, Saramago B, Serro A, Chauhan A
Pharm Res. 2023; 40(8):1939-1951.
PMID: 37498499
PMC: 10447275.
DOI: 10.1007/s11095-023-03560-7.
Peptide cargo administration: current state and applications.
Rohira H, Arora A, Kaur P, Chugh A
Appl Microbiol Biotechnol. 2023; 107(10):3153-3181.
PMID: 37052636
PMC: 10099029.
DOI: 10.1007/s00253-023-12512-5.
Chitosan-Covered Calcium Phosphate Particles Co-Loaded with Superoxide Dismutase 1 and ACE Inhibitor: Development, Characterization and Effect on Intraocular Pressure.
Popova E, Matveeva O, Beznos O, Tikhomirova V, Kudryashova E, Grigoriev Y
Pharmaceutics. 2023; 15(2).
PMID: 36839871
PMC: 9962464.
DOI: 10.3390/pharmaceutics15020550.
A Novel Ferroptosis Inhibitor UAMC-3203, a Potential Treatment for Corneal Epithelial Wound.
Balla A, Tran B, Valtari A, Steven P, Scarpellini C, Augustyns K
Pharmaceutics. 2023; 15(1).
PMID: 36678747
PMC: 9863691.
DOI: 10.3390/pharmaceutics15010118.
In vitro-in vivo correlation of drug release profiles from medicated contact lenses using an in vitro eye blink model.
Pereira-da-Mota A, Vivero-Lopez M, Garg P, Phan C, Concheiro A, Jones L
Drug Deliv Transl Res. 2022; 13(4):1116-1127.
PMID: 36528710
PMC: 9981533.
DOI: 10.1007/s13346-022-01276-6.
Nanoengineering the surface of corneal implants: towards functional anti-microbial and biofilm materials.
Khatoon Z, Guzman-Soto I, McTiernan C, Lazurko C, Simpson F, Zhang L
RSC Adv. 2022; 10(40):23675-23681.
PMID: 35517329
PMC: 9054791.
DOI: 10.1039/d0ra03659e.
Quantification of tear glucose levels and their correlation with blood glucose levels in dogs.
Lee E, Kang S, Shim J, Jeong D, Jeong Y, Ahn J
Vet Med Sci. 2022; 8(4):1816-1824.
PMID: 35305285
PMC: 9297779.
DOI: 10.1002/vms3.788.
Sustained release glaucoma therapies: Novel modalities for overcoming key treatment barriers associated with topical medications.
Belamkar A, Harris A, Zukerman R, Siesky B, Oddone F, Verticchio Vercellin A
Ann Med. 2022; 54(1):343-358.
PMID: 35076329
PMC: 8794062.
DOI: 10.1080/07853890.2021.1955146.
Ocular Fluid Mechanics and Drug Delivery: A Review of Mathematical and Computational Models.
Bhandari A
Pharm Res. 2021; 38(12):2003-2033.
PMID: 34936067
DOI: 10.1007/s11095-021-03141-6.
The Emerging Role of Topical Ocular Drugs to Target the Posterior Eye.
Wang L, Zhou M, Zhang H
Ophthalmol Ther. 2021; 10(3):465-494.
PMID: 34218424
PMC: 8319259.
DOI: 10.1007/s40123-021-00365-y.
In vivo comet assay in rabbit corneal epithelial cells following ocular instillation with genotoxic compounds.
Tahara H, Yamagiwa Y, Haranosono Y, Kurata M
Genes Environ. 2021; 43(1):11.
PMID: 33827709
PMC: 8028091.
DOI: 10.1186/s41021-021-00184-4.
Ocular and Systemic Pharmacokinetics of Brimonidine and Timolol After Topical Administration in Rabbits: Comparison Between Fixed-Combination and Single Drugs.
Suzuki G, Kunikane E, Shinno K, Kozai S, Kurata M, Kawamura A
Ophthalmol Ther. 2020; 9(1):115-125.
PMID: 31953739
PMC: 7054494.
DOI: 10.1007/s40123-020-00229-x.
Kinetics of Fluorescein in Tear Film After Eye Drop Instillation in Beagle Dogs: Does Size Really Matter?.
Sebbag L, Kirner N, Allbaugh R, Reis A, Mochel J
Front Vet Sci. 2020; 6:457.
PMID: 31921915
PMC: 6930880.
DOI: 10.3389/fvets.2019.00457.
